Kon-Kiki Pharma ApS: Financial statements 2024
CVR: 43311824
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Kon-Kiki Pharma ApS (CVR 43311824) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,484,454 and a net result of DKK 503,219 compared with DKK 603,209 the year before. That is a decrease of 12.2% compared with the year before. Equity in the 2024 report amounted to DKK 559,491. The solvency ratio was 57.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,484,454
- Profit/Loss
- DKK 503,219
- Equity
- DKK 559,491
- Total Assets
- DKK 969,212
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Kon-Kiki Pharma ApS has published its annual report for 2023. Gross profit came to DKK 1,690,401, and the net result was DKK 603,209.
About Kon-Kiki Pharma ApS
Kon-Kiki Pharma ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kiki Atting Andersen. The company is owned by Kiki Andersen Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,539,454 and a net result of DKK 419,959 compared with DKK 503,219 the year before. Equity in the 2025 report amounted to DKK 460,450.